Literature DB >> 17901551

Endocannabinoid liberation from neurons in transsynaptic signaling.

David M Lovinger1.   

Abstract

Endocannabinoids are fatty acid derivatives that have a variety of biological actions, most notably via activation of the cannabinoid receptors. These receptors are also targets for drugs derived from Cannabis sativa. In the nervous system, endocannabinoids act as neuromodulators that depress neurotransmitter release at the presynaptic terminal. In most instances of neural endocannabinoid signaling, the compounds appear to be released from the postsynaptic neuron to act on the presynaptic terminal in a "retrograde" manner. Several common mechanisms involved in postsynaptic endocannabinoid production and presynaptic depression produced via activation of the CB1 cannabinoid receptor have been identified. However, significant problems remain in defining the mechanisms underlying endocannabinoid production, release, and movement across the membrane. These issues are discussed in the present review.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17901551     DOI: 10.1007/s12031-007-0043-2

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  61 in total

1.  Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP.

Authors:  H Cadas; S Gaillet; M Beltramo; L Venance; D Piomelli
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

2.  Neighboring cerebellar Purkinje cells communicate via retrograde inhibition of common presynaptic interneurons.

Authors:  P Vincent; A Marty
Journal:  Neuron       Date:  1993-11       Impact factor: 17.173

3.  Membrane transport of anandamide through resealed human red blood cell membranes.

Authors:  Inge N Bojesen; Harald S Hansen
Journal:  J Lipid Res       Date:  2005-06-01       Impact factor: 5.922

Review 4.  Anandamide transport.

Authors:  Matthew J McFarland; Eric L Barker
Journal:  Pharmacol Ther       Date:  2004-11       Impact factor: 12.310

5.  Postsynaptic endocannabinoid release is critical to long-term depression in the striatum.

Authors:  G L Gerdeman; J Ronesi; D M Lovinger
Journal:  Nat Neurosci       Date:  2002-05       Impact factor: 24.884

6.  A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide.

Authors:  Matthew J McFarland; Amy C Porter; Fariborz R Rakhshan; Diwan S Rawat; Richard A Gibbs; Eric L Barker
Journal:  J Biol Chem       Date:  2004-08-03       Impact factor: 5.157

7.  Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells.

Authors:  T A Pitler; B E Alger
Journal:  J Neurosci       Date:  1992-10       Impact factor: 6.167

8.  Post-receptor mechanisms underlying striatal long-term depression.

Authors:  P Calabresi; A Pisani; N B Mercuri; G Bernardi
Journal:  J Neurosci       Date:  1994-08       Impact factor: 6.167

9.  Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala.

Authors:  A I Gulyas; B F Cravatt; M H Bracey; T P Dinh; D Piomelli; F Boscia; T F Freund
Journal:  Eur J Neurosci       Date:  2004-07       Impact factor: 3.386

10.  Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation.

Authors:  Mauro Maccarrone; Monica Bari; Natalia Battista; Alessandro Finazzi-Agrò
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

View more
  10 in total

1.  Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum.

Authors:  Peng Zhong; Bin Pan; Xiu-ping Gao; Jacqueline L Blankman; Benjamin F Cravatt; Qing-song Liu
Journal:  J Physiol       Date:  2011-09-12       Impact factor: 5.182

2.  Enhanced Glutamatergic Synaptic Plasticity in the Hippocampal CA1 Field of Food-Restricted Rats: Involvement of CB1 Receptors.

Authors:  Giuseppe Talani; Valentina Licheri; Francesca Biggio; Valentina Locci; Maria Cristina Mostallino; Pietro Paolo Secci; Valentina Melis; Laura Dazzi; Gianfranca Carta; Sebastiano Banni; Giovanni Biggio; Enrico Sanna
Journal:  Neuropsychopharmacology       Date:  2015-09-10       Impact factor: 7.853

3.  Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation.

Authors:  R Makwana; A Molleman; M E Parsons
Journal:  Br J Pharmacol       Date:  2010-03-05       Impact factor: 8.739

Review 4.  A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research.

Authors:  Matthew J Pava; John J Woodward
Journal:  Alcohol       Date:  2012-03-27       Impact factor: 2.405

5.  Kainate Receptors Inhibit Glutamate Release Via Mobilization of Endocannabinoids in Striatal Direct Pathway Spiny Projection Neurons.

Authors:  John J Marshall; Jian Xu; Anis Contractor
Journal:  J Neurosci       Date:  2018-03-14       Impact factor: 6.167

6.  Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity.

Authors:  Louise Adermark; Giuseppe Talani; David M Lovinger
Journal:  Eur J Neurosci       Date:  2009-01       Impact factor: 3.386

7.  Interactions between ethanol and the endocannabinoid system at GABAergic synapses on basolateral amygdala principal neurons.

Authors:  Giuseppe Talani; David M Lovinger
Journal:  Alcohol       Date:  2015-10-27       Impact factor: 2.405

Review 8.  Pursuing paradoxical proconvulsant prophylaxis for epileptogenesis.

Authors:  Caren Armstrong; Robert J Morgan; Ivan Soltesz
Journal:  Epilepsia       Date:  2009-07-01       Impact factor: 5.864

9.  Frequency-dependent inversion of net striatal output by endocannabinoid-dependent plasticity at different synaptic inputs.

Authors:  Louise Adermark; David M Lovinger
Journal:  J Neurosci       Date:  2009-02-04       Impact factor: 6.167

Review 10.  Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings.

Authors:  Andrew J Kesner; David M Lovinger
Journal:  J Neurochem       Date:  2021-05-16       Impact factor: 5.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.